1.A case of mullerian adenosarcoma of endometrium.
Joong Han YOON ; Min Hwa JEONG ; Jin Hong KIM ; Jong Gu RHA
Korean Journal of Obstetrics and Gynecology 1991;34(2):293-297
No abstract available.
Adenosarcoma*
;
Endometrium*
;
Female
2.A case of mullerian adenosarcoma of endometrium.
Joong Han YOON ; Min Hwa JEONG ; Jin Hong KIM ; Jong Gu RHA
Korean Journal of Obstetrics and Gynecology 1991;34(2):293-297
No abstract available.
Adenosarcoma*
;
Endometrium*
;
Female
3.MR Findings of Extrauterine Mullerian Adenosarcoma Associated with Deep Pelvic Endometriosis.
Dae Kun OH ; Chan Kyo KIM ; Byung Kwan PARK ; Ji Young KIM
Journal of the Korean Radiological Society 2008;58(2):163-167
Extrauterine mullerian adenosarcoma is a very rare tumor and it is characterized by a benign glandular component and a low-grade sarcomatous stromal component. These tumors have been reported to arise from ovarian or extraovarian endometriosis. However, there are scant reports on the MR findings of extrauterine mullerian adenosarcoma arising from deep pelvic endometriosis. We describe here a case of a large infiltrating extrauterine mullerian adenosarcoma arising from recurrent deep pelvic endometriosis and we discuss its MR findings.
Adenosarcoma
;
Endometriosis
;
Female
;
Mixed Tumor, Mullerian
;
Uterus
4.Mullerian adenosarcoma with sarcomatous overgrowth in a premenopausal patient
Celeste Zamuco-Francisco ; Renee Vina G. Sicam
Philippine Journal of Obstetrics and Gynecology 2020;44(3):44-48
We report a case of a 33-years old, nulligravid, diagnosed with mullerian adenosarcoma with sarcomatous overgrowth (MASO), who presented with vaginal bleeding and recurrent endometrial polyp. MASO is a rare type of uterine sarcomas, it is a variant of adenosarcomas with poor prognosis.
The index patient underwent primary surgical management with lymphadenectomy with a final stage of IC. Histologic diagnosis was Mulllerian adenosarcoma with sarcomatous overgrowth. A panel of immunostaining for estrogen receptors, progesterone receptors and CD 10 showed diffused positivity for the hormones with loss of CD 10 which is consistent with MASO.
The rarity of MASO has a distinctive histologic features which merits meticulous sectioning as the clinical course and management vary. It has a poor prognosis due to its short and fast course of the disease.
Adenosarcoma
;
Sarcoma
;
Uterine Neoplasms
;
Soft Tissue Neoplasms
5.Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature.
Rajan DUGGAL ; Raje NIJHAWAN ; Neelam AGGARWAL ; Pooja SIKKA
Journal of Gynecologic Oncology 2010;21(2):125-128
Mullerian adenosarcoma is a rare biphasic malignant neoplasm of the cervix characterized by an admixture of benign epithelial elements and a malignant sarcomatous stromal component, which may be either homologous or heterologous. An aggressive variant of adenosarcoma, mullerian adenosarcoma with sarcomatous overgrowth (MASO) is extremely rare, with only two such cases being reported in the English literature to date. In this report we present a case of MASO of uterine cervix with heterologous elements in a 15-year-old unmarried girl presenting with foul smelling menstrual bleeding and passage of fleshy masses. Because MASO with heterologous elements seems to appear at the earliest stages of reproductive lifespan in women, and have an uncertain malignant potential, gynecologists and pathologists should be aware and think about the possibility of this tumor.
Adenosarcoma
;
Adolescent
;
Cervix Uteri
;
Female
;
Hemorrhage
;
Humans
;
Single Person
;
Smell
6.A Case of Solitary Brain Metastasis from Uterine Mullerian Adenosarcoma with Sarcomatous Overgrowth.
Suk Bo HONG ; Min Jung KIM ; Ji Yeon KWON ; Seok Jin CHOI ; Eun Young KIM ; Joohan LIM
Brain Tumor Research and Treatment 2016;4(2):138-141
Uterine adenosarcoma (AS) are rare tumors and have more favorable outcomes than the aggressive uterine carcinosarcomas. Uterine adenosarcoma with sarcomatous overgrowth (ASSO) is a variant form of AS and exhibits aggressive growth of tumor and the prognosis is relatively poor compared with typical AS. Usually patterns of metastasis have been known to behave like endometrial carcinoma and spread through the lymphatics. Brain metastasis from uterine AS is extremely rare. Herein, we report a case of successfully surgically removed solitary brain metastasis without any extracranial recurrence from uterine ASSO after 4 years of primary treatment.
Adenosarcoma*
;
Brain*
;
Carcinosarcoma
;
Endometrial Neoplasms
;
Female
;
Neoplasm Metastasis*
;
Prognosis
;
Recurrence
7.Synchronous occurrence of primary malignant mixed mullerian tumor in ovary and uterus.
Tae Yeon LEE ; Chulmin LEE ; Won Jun CHOI ; Ji Young LEE ; Heung Yeol KIM
Obstetrics & Gynecology Science 2013;56(4):269-272
Malignant mixed mullerian tumor (MMMT) arising from female internal genitalia is rare with the uterine corpus being the most prevalently affected site. It is even more rare when it occurs on both uterus and ovary at the same time. We describe a case of synchronized occurrence of MMMT on ovary and uterine adenosarcoma with review of literature.
Adenosarcoma
;
Female
;
Genitalia
;
Humans
;
Ovary
;
Uterine Neoplasms
;
Uterus
9.A Case of Miillerian Adenosarcoma of the Uterus with Squamous Cell Carcinoma of the Uterine Cervix.
Joong Sik SHIN ; Nak Woo LEE ; Hai Joong KIM ; Young Sik KIM ; Chul Hwan KIM
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(2):200-204
Mullerian adenosarcoma is an uncommon variant of MQllerian mixed tumors of the uterus and a mixed, biphasic neoplasia in which the mesenchymal component is malignant and the epithelial component is benign. In contrast to typical malignant Miillerian mixed tumor(MMMT), Miillerian adenosarcomas are usually tumors of low malignant potential. These tumom usually present as pedunculated endometrial masses in postmenopausal women with vaginal bleeding. We experienced a case of Miillerian adenosarcoma of the uterus with squamous cell carcinoma of the uterine cervix and report with a brief review of literatures.
Adenosarcoma*
;
Carcinoma, Squamous Cell*
;
Cervix Uteri*
;
Female
;
Humans
;
Uterine Hemorrhage
;
Uterus*
10.Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.
Ye Won CHUNG ; Hyo Sook BAE ; Song I HAN ; Jae Yoon SONG ; In Sun KIM ; Jae Seong KANG
Journal of Gynecologic Oncology 2010;21(4):269-272
Toremifene is an anti-estrogen which has been shown to be effective in the treatment of breast cancer, and is thought to be a less uterotrophic agent than tamoxifen. The risk assessment concerning endometrial cancer has been inconclusive because of its rare use up to the mid-1990s. We report a case of an adenosarcoma, which is a very rare type of uterine malignancy, after toremifene treatment for 5 years in a breast cancer patient. After 1 year of toremifene use, the patient had a benign Mullerian adenofibroma. After an additional 4 years of toremifene treatment, the endometrial polypoid lesion was transformed into a Mullerian adenosarcoma. Although toremifene is a promising anti-estrogenic agent in the treatment of breast cancer patients, clinicians should not neglect the possibility of a uterine malignancy.
Adenofibroma
;
Adenosarcoma
;
Breast
;
Breast Neoplasms
;
Endometrial Neoplasms
;
Female
;
Humans
;
Risk Assessment
;
Tamoxifen
;
Toremifene